Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion.
The magnesium status was evaluated in 30 subjects with Crohn's disease and in 30 controls. Subjects with Crohn's disease had lower concentrations of magnesium in muscle biopsy specimens (p less than 0.001), mononuclear cells (p less than 0.05), and in urine collected during 24 h (p less than 0.001) as compared with controls. After intravenous infusion of 60 mmol magnesium and 80 mmol potassium to 17 subjects with Crohn's disease a significant increase in concentrations of magnesium in muscle specimens (p less than 0.05), mononuclear cells (p less than 0.01), and plasma (p less than 0.01) was noted. The retention of intravenously infused magnesium was significantly higher in subjects with Crohn's disease than in 11 healthy controls (p less than 0.001) and was inversely correlated with the content of magnesium in muscle specimens (r = -0.52; p less than 0.05). The implication of these findings is that analysis of magnesium in muscle specimens and estimation of magnesium retention during an intravenous magnesium infusion are useful to confirm a suspected magnesium deficiency.
Sjögren
A
A
Dept. of Internal Medicine, University Hospital of Lund, Sweden.
Florén
C H
CH
Nilsson
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D003424:Crohn Disease / Q000378:metabolism*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000032:analysis; D009132:Muscles / Q000032:analysis; D011188:Potassium / Q000008:administration & dosage / Q000032:analysis
D008274:Magnesium; D011188:Potassium